nephropathy

Related by string. Nephropathy * * diabetic nephropathy . IgA nephropathy . Contrast Induced Nephropathy CIN . overt nephropathy . chronic allograft nephropathy . hypertension diabetic nephropathy . contrast induced nephropathy . membranous nephropathy . Diabetic Nephropathy . Diabetic nephropathy . acute phosphate nephropathy . Contrast Induced Nephropathy *

Related by context. All words. (Click for frequent words.) 66 diabetes mellitus T2DM 66 T2DM 66 microalbuminuria 65 hepatic cirrhosis 65 renal dysfunction 65 overt nephropathy 65 diabetes mellitus 65 metaplasia 64 albuminuria 64 microvascular disease 64 proteinuria 64 macrovascular complications 64 ADPKD 64 choroidal neovascularization CNV 63 hyperparathyroidism 63 elevated triglyceride levels 63 extrapyramidal symptoms 63 hyperglycaemia 63 PAOD 63 β blockers 63 hyperinsulinemia 63 coagulopathy 63 macroalbuminuria 63 preserved ejection fraction 63 arterial hypertension 63 hepatorenal syndrome 63 colorectal carcinoma 63 hypercoagulable 63 systemic amyloidosis 63 nonalcoholic steatohepatitis 63 steatohepatitis 63 airway hyperresponsiveness 63 hypercholesterolemia 62 diabetes mellitus DM 62 left ventricular dysfunction 62 intracranial hemorrhage ICH 62 proliferative diabetic retinopathy 62 nonischemic 62 hepatotoxicity 62 hepatic fibrosis 62 SSc 62 G6PD deficiency 62 microvascular complications 62 thyrotoxicosis 62 glucose intolerance 62 nephrotoxicity 62 haematopoietic 62 Torsades de Pointes 62 lactic acidosis 62 liver fibrosis 62 diabetic kidney 62 renal insufficiency 62 serum creatinine levels 62 IDDM 62 interstitial pneumonia 62 lipid abnormalities 62 APOL1 62 lymphadenopathy 62 cerebral ischemia 62 dysfunction LVSD 62 diabetic microvascular complications 62 GRNCM1 62 choroidal neovascularization 62 hypoxemia 62 renal scarring 62 endometrial hyperplasia 62 carotid plaques 62 left ventricular systolic 62 liver metastasis 61 glomerulonephritis 61 colorectal adenoma 61 neovascular 61 hypercalciuria 61 hemolytic anemia 61 renal fibrosis 61 ABCB1 61 HBeAg negative 61 triglyceride concentrations 61 adrenal insufficiency 61 aortic regurgitation 61 fibrosis 61 calculi 61 Lupus nephritis 61 hematopoietic cancers 61 hypercalcaemia 61 motor neuron degeneration 61 gastric adenocarcinoma 61 Non Alcoholic Fatty 61 Zollinger Ellison Syndrome 61 hyperplastic 61 atrophic gastritis 61 cerebral vasospasm 61 hyperkalemia 61 Microalbuminuria 61 atherogenic dyslipidemia 61 mucinous 61 antiphospholipid syndrome 61 glycated hemoglobin levels 61 hibernating myocardium 61 isoenzyme 61 Candida infection 61 cystic fibrosis chronic pancreatitis 61 unresectable tumors 61 LV dysfunction 61 renal disease 61 microangiopathy 61 PTLD 61 dysglycemia 61 hamartomas 61 cardiac fibrosis 61 HIVAN 61 neurological manifestations 61 paraneoplastic 61 hyperlipidemia 61 arterial calcification 61 arrhythmogenic 61 dyslipidaemia 61 liver histology 60 Erythropoietic therapies may 60 neurologic symptoms 60 nondiabetic patients 60 thromboembolic complications 60 mitochondrial toxicity 60 K ras mutations 60 metabolic acidosis 60 fibrosis scarring 60 cytopenias 60 monogenic 60 contrast induced nephropathy 60 hypophosphatemia 60 varices 60 amyloid deposition 60 diabetes dyslipidemia 60 Hashimoto thyroiditis 60 autonomic dysfunction 60 lichen planus 60 thrombotic events 60 ventricular remodeling 60 T1DM 60 sCJD 60 pericardial effusion 60 metabolic abnormalities 60 mixed hyperlipidemia 60 myocardial ischemia 60 pulmonary dysfunction 60 hemorrhagic complications 60 GH deficiency 60 hyperprolactinemia 60 gestational diabetes mellitus 60 cirrhosis liver failure 60 allograft rejection 60 aortic valve stenosis 60 glomerular filtration rate 60 Haptoglobin 60 eplerenone 60 diabetic nephropathy 60 fibrin deposition 60 MetS 60 systolic dysfunction 60 AST ALT 60 prostate carcinoma 60 granulomatous 60 Cushing syndrome 60 secondary hyperparathyroidism 60 neovascularization 60 cardiac dysfunction 60 pheochromocytoma 60 pancreatic adenocarcinoma 60 gastric carcinoma 60 insulin resistance 60 hyperhomocysteinemia 60 monocytic 60 lupus anticoagulant 60 prostate cancer CaP 60 CTEPH 60 endothelial dysfunction 60 leiomyomas 60 coagulation abnormalities 60 Vitamin B# deficiency 60 atherothrombotic 60 bladder tumors 60 metabolic disturbances 60 heterotaxy 60 bullous 60 gallstone disease 60 lung fibrosis 60 arthropathy 60 vasculopathy 60 1 diabetes T1D 60 immunocompetent 60 cerebral infarction 60 tumor necrosis 60 Sezary syndrome 60 decompensated cirrhosis 60 SHPT 60 proliferative retinopathy 60 macrovascular disease 60 autoimmune thyroid 60 adenomatous 60 genetic polymorphism 60 hematologic toxicity 60 gastrointestinal perforation 59 bone marrow suppression 59 pyelonephritis 59 urothelial carcinoma 59 HIV HCV coinfected 59 neovascularisation 59 MYH9 gene 59 advanced adenomas 59 Hypotension 59 metastatic malignant 59 haemolysis 59 hypoperfusion 59 arterial thrombosis 59 methylenetetrahydrofolate reductase 59 advanced adenoma 59 acute GVHD 59 Proteinuria 59 pancytopenia 59 atrial arrhythmias 59 CYP #A# 59 hydrops 59 polycythemia vera PV 59 torsade de pointes 59 onset diabetes mellitus 59 underlying pathophysiology 59 impaired glucose tolerance 59 left ventricular hypertrophy 59 LVNC 59 NYHA Class II 59 postoperative AF 59 mycosis fungoides 59 CP CPPS 59 dilated cardiomyopathy DCM 59 sulfasalazine 59 cardiomyopathies 59 cholelithiasis 59 endophthalmitis 59 transaminase elevations 59 microsatellite instability 59 cystic lesions 59 reperfusion injury 59 QTc prolongation 59 infarcts 59 lacunar 59 isoenzymes 59 cardiovascular disease hypertension 59 pathophysiologic 59 immunodeficiency 59 ischemia reperfusion injury 59 elevated IOP 59 transaminase levels 59 retinopathy 59 geographic atrophy 59 prostate carcinogenesis 59 candidemia 59 chronic HBV infection 59 valvular disease 59 renal impairment 59 induce orthostatic hypotension 59 ischemic cardiomyopathy 59 hydronephrosis 59 renal allograft 59 thromboembolism 59 invasive ductal 59 Glucocorticoids 59 vWD 59 neoplastic lesions 59 prothrombotic 59 hematologic disorders 59 Endothelial dysfunction 59 cholangiocarcinoma 59 colorectal tumors 59 thromboembolic events 59 C. trachomatis 59 heparin induced thrombocytopenia 59 congenital deficiency 59 Diabetic nephropathy 59 neoplastic 59 inotropic 59 interstitial fibrosis 59 valvular heart disease 59 pT3 59 hypocalcaemia 59 follicular lymphomas 59 CC genotype 59 E selectin 59 juvenile idiopathic arthritis JIA 59 NAFLD 59 TNFa 59 vaso occlusive crisis 59 Non Alcoholic Steatohepatitis 59 leukemia AML 59 Neovascular AMD 59 vascular inflammation 59 glomerular filtration 59 renal function 59 esophageal varices 59 nitrotyrosine 59 ischemic mitral regurgitation 59 pathologic myopia 59 distant metastases 59 pulmonary metastasis 59 prostate cancer PCa 59 unknown etiology 59 progressive dyspnea 59 variceal bleeding 59 nasopharyngeal carcinoma 59 CMV disease 59 hypertensives 59 DFMO 59 ischemic complications 59 MGUS 59 adrenocortical cancer 59 anterior uveitis 59 bacteriuria 59 AAT deficiency 59 fulminant hepatic failure 59 airway hyper responsiveness 58 HNSCC 58 atherosclerotic disease 58 apoA 58 primary aldosteronism 58 MPGN 58 LPS induced 58 pericardial effusions 58 postoperative pulmonary 58 ANCA associated 58 acute decompensation 58 H pylori 58 bexarotene 58 intracerebral 58 invasive candidiasis 58 HER2 overexpression 58 Ribavirin causes 58 fibrogenesis 58 coronary calcification 58 Zollinger Ellison syndrome 58 vertebral fracture 58 familial amyloidotic polyneuropathy FAP 58 perioperative complications 58 Thiazolidinediones 58 steatosis 58 nonalcoholic steatohepatitis NASH 58 nodal metastasis 58 radiotherapy RT 58 hyperresponsiveness 58 T2D 58 Eisenmenger syndrome 58 parkinsonism 58 aminotransferases 58 thromboembolic disease 58 parathyroid carcinoma 58 CrCl 58 hepatic 58 antitumor effect 58 paricalcitol 58 familial adenomatous polyposis 58 ovarian carcinoma 58 Hemorrhagic 58 epithelial tumors 58 subclinical hyperthyroidism 58 hypercholesterolaemia 58 lipid lowering therapies 58 inducible nitric oxide synthase 58 PDGFR 58 haemolytic anemia 58 renal kidney 58 serum triglycerides 58 chronic rhinosinusitis 58 vascular dysfunction 58 tuberculous 58 adrenalectomy 58 PCa 58 collagen degradation 58 kidney insufficiency 58 atherothrombosis 58 mesangial 58 hepatocellular carcinoma 58 prostatic tissue 58 TPMT 58 subclinical 58 hypercalcemia 58 NSAID induced 58 POAG 58 Adenomas 58 carotid IMT 58 IL6 58 hypertriglyceridemia 58 C. pneumoniae 58 hepatic steatosis 58 renal toxicity 58 atherosclerotic lesions 58 coronary artery aneurysms 58 pDC 58 endotoxemia 58 alanine aminotransferase 58 lymphocytic 58 esophageal carcinoma 58 aminotransferase 58 Sjögren syndrome 58 acute rheumatic fever 58 nonmelanoma skin cancers 58 distensibility 58 diastolic dysfunction 58 NMIBC 58 skeletal metastases 58 Leydig cell 58 morphometric vertebral fractures 58 experimental autoimmune encephalomyelitis 58 atypical hemolytic uremic syndrome 58 ocular disorders 58 lymphocytosis 58 gastric atrophy 58 glomerular 58 cataract formation 58 vasodilatory 58 TEAEs 58 myeloproliferative diseases 58 osteosarcomas 58 urolithiasis 58 myocardial ischaemia 58 MALT lymphoma 58 esophageal squamous cell carcinoma 58 Papillary 58 Thrombocytopenia 58 xenograft tumors 58 hepatic insufficiency 58 orchitis 58 nonfatal MI 58 IL 1ß 58 liver scarring 58 neurological complications 58 endothelial activation 58 systolic hypertension 58 thrombocytosis 58 subependymal giant cell 58 anthracycline induced 58 hypothalamic pituitary 58 chromosomal rearrangement 58 pulmonary hypertension PH 58 methemoglobinemia 58 folic acid deficiency 58 myocardial fibrosis 58 Barrett esophagus BE 58 aminotransferase levels 58 autoantibody levels 58 hepatocellular 58 breast carcinoma 58 chromosomal mutations 58 HMG CoA reductase inhibitors 58 Acidosis 58 calcium oxalate stones 58 infarctions 58 diabetic retinopathy DR 58 node metastases 58 leptin deficiency 58 hepatic liver 58 ventricular dysfunction 58 left ventricular LV 58 thrombotic complications 58 papillary carcinoma 58 noncardiovascular 58 familial adenomatous polyposis FAP 58 chronic GVHD 58 vasodilatation 58 hepatic dysfunction 58 gastric carcinogenesis 58 hemorrhagic cystitis 58 cardiovascular mortality 58 thrombocytopenic 58 lymph node metastasis 58 valvular 58 Cryptococcus neoformans 58 kidney urologic 58 myocardial infarct 58 retransplantation 58 pancreatic insufficiency 58 dermatomyositis 58 recurrent glioblastoma multiforme 58 asplenia 58 gastrointestinal GI perforation 58 rs# [002] 58 occlusion CRVO 58 breast endometrial 58 renal tumors 58 hepatic enzymes 58 histopathological 58 chronic renal disease 58 coinfection 58 fulminant hepatitis 57 prolonged QT interval 57 cholestasis 57 heterozygotes 57 comorbid conditions 57 transgene expression 57 thyroid dysfunction 57 nephrolithiasis 57 CMV infections 57 Helicobacter pylori infection 57 glycosylated hemoglobin HbA1c 57 distant metastasis 57 paroxysmal AF 57 dopaminergic therapy 57 antiplatelet medications 57 hyperalgesia 57 ocular toxicity 57 mediastinitis 57 hypogonadotropic hypogonadism 57 Hematologic 57 hypoplasia 57 eosinophilia 57 testicular tumors 57 angiographically 57 GRK5 57 KRAS mutation 57 salmeterol HFA MDI 57 CVD mortality 57 homozygotes 57 NPM1 mutation 57 plasma triglycerides 57 cardioembolic stroke 57 hepatic failure 57 thrombocytopenia neutropenia 57 platelet activation 57 systemic lupus erythematosus 57 mitral stenosis 57 hepatocellular carcinomas 57 von Willebrand disease 57 acute aortic dissection 57 hypotensive 57 ventricular arrhythmia 57 spinocerebellar ataxia 57 interleukin IL -# 57 ß blockers 57 myocardial dysfunction 57 primary hyperparathyroidism 57 nondiabetics 57 syngeneic 57 neointimal hyperplasia 57 Chlamydia pneumoniae 57 ATACAND 57 renal artery stenosis 57 unmeasured confounders 57 fluid overload 57 non alcoholic steatohepatitis 57 NNT = 57 AA Amyloidosis 57 basal cell nevus syndrome 57 neoplasms 57 PKC beta 57 androgen deprivation 57 intact parathyroid hormone 57 gestational hypertension 57 caveolin 57 hepatic lipase 57 cryptogenic 57 olmesartan 57 invasive fungal infection 57 colorectal carcinogenesis 57 immunosuppressive therapies 57 ADAMTS# 57 gene polymorphism 57 malperfusion 57 Pulmonary hypertension 57 complement inhibitor eculizumab 57 papillary RCC 57 cardiac hypertrophy 57 primidone 57 biliary tract disease 57 atherosclerotic vascular disease 57 hepatic toxicity 57 obstructive coronary 57 Insulin detemir 57 hyperuricemia 57 QT interval prolongation 57 imatinib resistance 57 pentoxifylline 57 myelosuppression 57 prognostic significance 57 Genetic variants 57 Critical limb ischemia 57 predisposing factor 57 SCr 57 microvascular dysfunction 57 Carcinoid tumors 57 chlamydial 57 anti fibrotic 57 verapamil 57 neutropenia thrombocytopenia 57 monocyte chemoattractant protein 57 fatty degeneration 57 diabetic complications 57 leucopenia 57 chronic pancreatitis 57 cardioprotection 57 normotensive 57 systemic corticosteroid 57 GISTs 57 leukoencephalopathy 57 hyperplasia 57 iron overload 57 hyperplastic polyps 57 adrenergic receptors 57 ventricular arrhythmias 57 posaconazole 57 intravesical therapy 57 occlusive disease 57 LV ejection fraction 57 TNF α 57 ductal adenocarcinoma 57 neurologic complications 57 multisystem disease 57 macrovascular events 57 pernicious anemia 57 neutrophil counts 57 antiplatelet drugs 57 autoantibodies 57 hepatic metastases 57 serum calcium levels 57 Hp2 2 57 carcinoid tumor 57 metastatic neuroendocrine tumors 57 tumoral 57 neoplasias 57 antihypertensive therapy 57 multivariate Cox 57 metabolic syndrome 57 HLA DRB1 * 57 cardiac tamponade 57 HBeAg 57 obstructive coronary artery 57 progressive neurodegenerative disorder 57 fibrotic disease 57 amenorrhoea 57 femoral neck fracture 57 pharmacologic intervention 57 alveolar epithelial cells 57 NNRTI resistance 57 decompensated heart failure 57 multidrug resistance 57 fatty acid oxidation 57 experimentally induced 57 thyrotropin 57 infective endocarditis 57 vasogenic edema 57 HMGA1 57 aplasia 57 abnormal angiogenesis 57 cell adhesion molecule 57 chronic thromboembolic pulmonary 57 valvular heart 57 aspartate aminotransferase 57 leukocytosis 57 selective modulator 57 C1q 57 aHUS 57 cranial irradiation 57 malignant lymphoma 57 dominantly inherited 57 chronic HCV infection 57 atherosclerotic cardiovascular disease 57 hyperglycemia 57 myocardial infarction 57 polyposis 57 paroxysmal nocturnal hemoglobinuria 57 Ischemic 57 liver transplant recipients 57 intermittent claudication 57 PsA 57 hyperlipemia 57 myopathy 57 CMV infection 57 HeFH 57 sarcomatoid 57 activin 57 isotypes 57 anemias 57 hemolytic uremic syndrome HUS 57 idiopathic pulmonary 57 endometrial carcinoma 57 abdominal adiposity 57 pathologic fractures 57 Mitral regurgitation 57 BCR ABL mutations 57 erythropoiesis 57 Chronic Prostatitis 57 elevated serum creatinine 57 parkinsonian symptoms 57 proteoglycan 57 vivax 57 disease progression 57 elevated fasting glucose 57 abacavir Ziagen 57 isolated systolic hypertension 57 null mice 57 platelet dysfunction 57 erythropoietic 57 cellularity 57 underlying vasculopathy 57 neoplasm 57 liver dysfunction 57 parasitemia 57 pulmonary metastases 57 HOMA IR 57 tumor xenograft models 57 leiomyoma 57 polyomavirus nephropathy 57 cytomegalovirus infection 57 postoperative infections 57 Thal Dex 57 Aspergillus species 57 cirrhotic 57 hypertension 57 lung metastasis 57 interferon IFN 57 plasma kallikrein 57 SGPT 57 IPAH 57 ACTOS ® 57 genital ulcers 57 metastatic RCC 57 alanine aminotransferase ALT 57 hyperammonemia 57 optic neuropathy 57 fractional shortening 57 inflammatory rheumatic 57 Orthostatic hypotension 57 elevated ALT 57 plasminogen activators 57 CTAP# Capsules 57 cardiac repolarization 57 pulmonary exacerbations 57 pulmonary artery banding 57 aldosterone antagonist 57 aortic root replacement 57 lactate dehydrogenase LDH 57 serum urate levels 57 recurrent VTE 57 missense mutation 57 Hyperlipidemia 57 Insulin resistance 57 abnormal glucose tolerance 57 T1a 57 diastolic heart 57 esophagogastric 57 noncardiac 57 urothelial cancer 57 HDL2 57 G6PD 57 proliferator activated receptor 57 amisulpride 57 MULTAQ 57 RAS mutations 57 transplantation HCT 57 IL 1beta 57 fibrosis cirrhosis 57 carotid stenosis 57 alcoholic fatty liver 57 symptomatic VTE 57 eosinophilic 57 thromboembolic 57 TGF beta signaling 57 intraoperative complications 57 cirrhosis 56 subclinical atherosclerosis 56 refractory gout 56 Clusterin 56 coinfected patients 56 HBeAg positive 56 NPH insulin 56 torsades de pointes 56 basal cell carcinoma BCC 56 Aortic stenosis 56 pancreatectomy 56 lung edema 56 sJIA 56 hippocampal atrophy 56 graft dysfunction 56 essential thrombocythemia 56 myopathy rhabdomyolysis 56 β cell 56 SGLT2 56 mTOR inhibitors 56 carcinoids 56 symptomatic intracranial 56 hyperlipidaemia 56 Retinopathy 56 Exacerbation 56 adenocarcinomas 56 comorbidities 56 Toxicities 56 confidence interval #.#-#.# 56 embolic stroke 56 immunosuppressive agents 56 colon carcinoma 56 monoclonal gammopathy 56 serum aminotransferase levels 56 nonhematologic adverse reactions 56 severe neutropenia 56 bronchial hyperresponsiveness 56 ertapenem 56 serum creatinine 56 sinus bradycardia 56 eosinophilic pneumonia 56 pharmacokinetic interactions 56 hepatocellular carcinoma HCC 56 biochemical abnormalities 56 antithyroid 56 corneal ectasia 56 gene polymorphisms 56 TNFalpha 56 HepG2 cells 56 serum phosphate 56 Ischaemic heart 56 prostate cancer CRPC 56 peritoneal carcinomatosis 56 invasive aspergillosis 56 alkaline phosphatase ALP 56 calcineurin inhibitors 56 latent celiac disease 56 thiazide diuretic 56 elevated lipase 56 myopathies 56 myeloperoxidase 56 anastomotic leak 56 euthyroid 56 neurocognitive deficits 56 myeloproliferative neoplasms 56 intimal hyperplasia 56 neovascular AMD 56 coronary blockages 56 endoleaks 56 ductal breast cancer 56 albumin excretion 56 invasive fungal infections 56 KCNE2 56 familial hypercholesterolemia FH 56 atherogenesis 56 mediated inhibition 56 supratentorial 56 acarbose 56 predisposing factors 56 ischemic colitis 56 metabolic derangements 56 reflux esophagitis 56 amnestic mild cognitive impairment 56 haptoglobin 56 hemodilution 56 germline mutations 56 cytopenia 56 ventricular dilation 56 erlotinib Tarceva ® 56 nonvertebral fractures 56 beta blocker therapy 56 endoleak 56 hypovolemic 56 acute myocardial infarction 56 CPVT 56 glomerulosclerosis 56 TTR amyloidosis 56 vessel occlusion 56 cardiac allograft vasculopathy 56 IGF2 56 neurotrophic 56 Vitamin D insufficiency 56 extramedullary 56 retinal ischemia 56 androgen deficiency 56 serum potassium 56 NKX2 56 inhibitor RG# 56 lipid levels 56 thymectomy 56 HBV replication 56 pulmonary infiltrates 56 granulocyte 56 intestinal metaplasia 56 apolipoprotein E gene 56 familial hypercholesterolemia 56 bronchopulmonary dysplasia 56 aortic atherosclerosis 56 upper gastrointestinal bleeding 56 serous ovarian cancer 56 β thalassemia 56 ischaemia 56 pretransplant 56 postoperative complication 56 erythematosus SLE 56 locoregional recurrence 56 mtDNA mutations 56 Thromboembolic 56 electrolyte abnormalities 56 Kupffer cells 56 tachyarrhythmias 56 hypoglycaemic episodes 56 hormonal disorder 56 polyp recurrence 56 plasma lipid 56 Polymorphisms 56 cardiac insufficiency 56 Elevated serum 56 Polycythemia vera 56 sotalol 56 acidosis 56 carcinoid tumors 56 platelet reactivity 56 lung adenocarcinomas 56 adenoma 56 Heavy menstrual bleeding 56 psychiatric comorbidity 56 IGFD 56 pT2 56 herpes zoster shingles 56 interstitial nephritis 56 elevated blood glucose 56 Lp PLA 2 56 metastatic lung cancer 56 atherosclerosis 56 chronic metabolic acidosis 56 renal carcinoma 56 serum PTH 56 Severe Primary IGFD 56 uricase 56 Legg Calvé Perthes disease 56 Primary IGFD 56 papillary renal cell carcinoma 56 serum ALT 56 osteochondromas 56 artery stenosis 56 Host Disease GvHD 56 epithelioid 56 serum GGT 56 acute humoral rejection 56 terlipressin 56 chronic hemodialysis 56 malignant transformation 56 cardiolipin 56 metabolic parameters 56 metabolic dysfunction 56 hypercholesterolemic patients 56 LV hypertrophy 56 penetrance 56 prognostic variables 56 haemorrhagic 56 hyperlipidemic 56 etiologic 56 reflux disease 56 urine NGAL 56 corticosteroid therapy 56 postoperative atrial fibrillation 56 intestinal polyps 56 collagenous colitis 56 unstable angina pectoris 56 bezafibrate 56 IL 1β 56 elevated triglycerides 56 uremia 56 natriuretic peptides 56 IGFBP 56 corneal epithelial 56 lung lesions 56 serum PSA 56 hypertension diabetes mellitus 56 serum lipid levels 56 autoantibody 56 vascularisation 56 Intussusception 56 #beta hydroxysteroid dehydrogenase 56 PTPN# 56 apolipoproteins 56 invasive carcinomas 56 herpesviruses 56 silent ischemia 56 creatinine ratio 56 cell carcinomas 56 autosomal dominant polycystic kidney 56 osteoid 56 impaired renal 56 pyrazinamide 56 del 5q MDS 56 hepatoma 56 histologic subtype 56 vascular reactivity 56 malignant neoplasms 56 anemia neutropenia 56 cTnT 56 chronic hepatitis cirrhosis 56 clomipramine 56 hemolytic 56 choroidal 56 Venous thromboembolism 56 corneal edema 56 chronicity 56 Ischemic heart 56 Hypoglycaemia 56 cTnI 56 histologic 56 eosinophil count

Back to home page